Skip to main content
. 2022 Nov 10;615(7953):687–696. doi: 10.1038/s41586-022-05531-1

Extended Data Table 2.

Targeted neoantigen, manufacturing process, neoTCR transfection efficiency and function for each clinical infused product to the 16 patients in this cohort

graphic file with name 41586_2022_5531_Tab2_ESM.jpg